BIRADS 3 and 4 lesions viewed by ultrasound and not seen in digital mammograms and tomosynthesis.

Similar documents
Imaging in breast cancer. Mammography and Ultrasound Donya Farrokh.MD Radiologist Mashhad University of Medical Since

Amammography report is a key component of the breast

Intracystic papillary carcinoma of the breast

BI-RADS classification in breast tomosynthesis. Our experience in breast cancer cases categorized as BI-RADS 0 in digital mammography

S. Murgo, MD. Chr St-Joseph, Mons Erasme Hospital, Brussels

Breast Imaging Lexicon

The Radiology Aspects

Digital breast tomosynthesis (DBT) occult breast cancers: clinical, radiological and histopathological features.

EARLY DETECTION: MAMMOGRAPHY AND SONOGRAPHY

Does elastography change the indication to biopsy? IBDC

ISSN X (Print) Research Article. *Corresponding author Dr. Amlendu Nagar

Since its introduction in 2000, digital mammography has become

Diagnostic benefits of ultrasound-guided. CNB) versus mammograph-guided biopsy for suspicious microcalcifications. without definite breast mass

Digital Breast Tomosynthesis from a first idea to clinical routine

Epworth Healthcare Benign Breast Disease Symposium. Sat Nov 12 th 2016

Diagnostic Dilemmas of Breast Imaging

Here are examples of bilateral analog mammograms from the same patient including CC and MLO projections.

ACRIN 6666 IM Additional Evaluation: Additional Views/Targeted US

EARLY DETECTION: MAMMOGRAPHY AND SONOGRAPHY

BI-RADS Update. Martha B. Mainiero, MD, FACR, FSBI Brown University Rhode Island Hospital

Standard Breast Imaging Modalities. Lilian Wang, M.D. Breast Imaging Section Department of Radiology Northwestern Medicine

8/31/2016 HIDING IN PLAIN SITE, ARCHITECTURAL DISTORTIONS AND BREAST ASYMMETRIES ARCHITECTURAL DISTORTIONS ARCHITECTURAL DISTORTIONS

Breast Cancer Imaging

Policy Library Clinical Advantages of Digital Breast Tomosynthesis in Symptomatic Patients

Disclosures. Breast Cancer. Breast Imaging Modalities. Breast Cancer Screening. Breast Cancer 6/4/2014

DR AISHA A UMAR CHIEF CONSULTANT RADIOLOGIST NATIONAL HOSPITAL ABUJA.

Breast asymmetries in mammography: Management

Breast Imaging & You

Hiding in Plain Sight / Site: Archictectural Distortions and Breast Asymmetries

OPTO-ACOUSTIC BREAST IMAGING

Breast Imaging & You

Leonard M. Glassman MD

Contrast-Enhanced Spectral Mammography

AMSER Case of the Month: November 2018

Detailed Program of the second BREAST IMAGING AND INTERVENTIONS PROGRAM am am : Clinician s requirements from breast imaging

Current Status of Supplementary Screening With Breast Ultrasound

Current Imaging Diagnosis of the Breast Tumors

Dense Breasts, Get Educated

Breast Imaging Update: Old Dog New Tricks

Mammography and Subsequent Whole-Breast Sonography of Nonpalpable Breast Cancers: The Importance of Radiologic Breast Density

BI-RADS 3 category, a pain in the neck for the radiologist which technique detects more cases?

Pitfalls and Limitations of Breast MRI. Susan Orel Roth, MD Professor of Radiology University of Pennsylvania

Ana Sofia Preto 19/06/2013

BARC/2013/E/019 BARC/2013/E/019. AUDIT OF MAMMOGRAPHY PERFORMED IN OUR HOSPITAL by Surita Kantharia Medical Division

Intracystic Papillary Carcinoma of the Breast: Clinical and Radiological Findings with Histopathologic Correlation

RADIOLOGIC EVALUATION OF BREAST CANCER

WHAT TO EXPECT. Breast Tomosynthesis An additional screening tool in the fight against breast cancer HOLOGIC. The Women's Health Company

Mammography. What is Mammography? What are some common uses of the procedure?

Cairo/EG, Khartoum/SD, London/UK Biological effects, Diagnostic procedure, Ultrasound, Mammography, Breast /ecr2015/C-0107

AMSER Case of the Month: September 2018

FALSE NEGATIVES IN MAMMOGRAPHY

Mammography limitations. Clinical performance of digital breast tomosynthesis compared to digital mammography: blinded multi-reader study

A-005 US DIAGNOSIS OF NONPALPABLE BREAST LESIONS

Original Report. Mucocele-Like Tumors of the Breast: Mammographic and Sonographic Appearances. Katrina Glazebrook 1 Carol Reynolds 2

Breast imaging in general practice

CURRENTLY FDA APPROVED ARE FULL FIELD DIGITAL MAMMOGRAPHY SYSTEMS AND FILM SCREEN STILL BEING USED AT SOME INSTITUTIONS

Correlation between lesion type and the additional value of digital breast tomosynthesis

Metachronic solitary breast metastasis from renal cell carcinoma: case report

Does the synthesised digital mammography (3D-DM) change the ACR density pattern?

Radiologic Findings of Mucocele-like Tumors of the breast: Can we differentiate pure benign from associated with high risk lesions?

Financial Disclosures

Breast Tomosynthesis An additional screening tool in the fight against breast cancer

TOMOSYNTHESIS: WORTH ALL THE HYPE?

Breast Ultrasound: Improving Your Skills & Patient Care

Breast Pathology in Men: Radiologic-Pathologic Correlation

Ultrasonography. Methods. Brief Description. Indications. Device-related Prerequisites. Technical Requirements. Evaluation Criteria

The radiologic workup of a palpable breast mass

Observer Agreement Using the ACR Breast Imaging Reporting and Data System (BI-RADS)-Ultrasound, First Edition (2003)

Case Report Tubular Carcinoma of the Breast: Advantages and Limitations of Breast Tomosynthesis

Supplemental Screening for Dense Breasts. Reagan Leverett, MD, MS

«àπ π â Õ μ «å «π Áß μâ π π ßæ π ª

Mammographic imaging of nonpalpable breast lesions. Malai Muttarak, MD Department of Radiology Chiang Mai University Chiang Mai, Thailand

Cystic Hypersecretory Carcinoma of the Breast:

Electrical impedance scanning of the breast is considered investigational and is not covered.

Breast Tomosynthesis. What is breast tomosynthesis?

THE MALE BREAST CARCINOMA: EARLY DETECTION HOPE. Author (s) Supreethi Kohli a, Pragya Garg b

Benign, Reactive and Inflammatory Lesions of the Breast

Malignant transformation of fibroadenomas

Complex cystic breast lesions, which are defined as lesions

THYROID NODULES: THE ROLE OF ULTRASOUND

A comparison of the accuracy of film-screen mammography, full-field digital mammography, and digital breast tomosynthesis

ORIGINAL ARTICLE EVALUATION OF BREAST LESIONS USING X-RAY MAMMOGRAM WITH HISTOPATHOLOGICAL CORRELATION

Clinical Study Mammographic Breast Density Patterns in Asymptomatic Mexican Women

BI-RADS and Breast MRI. Kathy Borovicka, M.D. Thursday February 15, 2018

Imaging the Symptomatic Patient. Avice M.O Connell MD,FACR,FSBI Professor of Imaging Sciences Director, Women s Imaging University of Rochester

Radiologic and pathologic correlation of non-mass like breast lesions on US and MRI: Benign, high risk, versus malignant

Radiologic and pathologic correlation of non-mass like breast lesions on US and MRI: Benign, high risk, versus malignant

Aims and objectives. Page 2 of 10

Pathologic outcomes of coarse heterogeneous calcifications detected on mammography

Elastosonography. Prof. Massimo Midiri Direttore Istituto di Radiologia Policlinico Universitario Paolo Giaccone Diagnostica per Immagini, - Palermo

Breast Health and Imaging Glossary

Breast Imaging Donald L. Renfrew, MD

Mammography. What is Mammography?

Proven clinical effectiveness at low radiation dose

Using Automated Breast Sonography as Part of a Multimodality Approach to Dense Breast Screening

Breast calcification: Management and Pictorial Review

Mammographic evaluation of palpable breast masses with pathological correlation: a tertiary care centre study in Nepal

Ultrasound of the Breast BASICS FOR THE ORDERING CLINICIAN

Tomosynthesis and breast imaging update. Dr Michael J Michell Consultant Radiologist King's College Hospital NHS Foundation Trust

Role of Elastography in the Evaluation of Breast Lesions

Transcription:

Original article Anales de Radiología México 2016 Jul;15(3):205-213. BIRADS 3 and 4 lesions viewed by ultrasound and not seen in digital mammograms and tomosynthesis. García-Quintanilla JF 1, González-Coronado SI 2, Gascón-Montante A 2, Hernández-Beltrán L 2, Barrera-López F 2, Lavín-Ayala R 2 Abstract OBJECTIVE: analyze the usefulness of ultrasound in detection of breast cancer, at a mammary gland imaging center, focusing primarily on nodules not seen in digital mammograms and tomosynthesis, in a prospective study of 1,600 mammograms for screening. INTRODUCTION: the mammogram, in its analogic or digital mode, is well known as an effective imaging method for early detection of breast cancer and the only screening method which proven to reduce mortality from breast cancer; however, superimposition of mammary tissue, added to its high density, are obstacles to interpreting and detecting lesions even when using digital mammogram by tomosynthesis, for which reason complementary use of ultrasound is imperative to detect lesions. MATERIAL AND METHODS: 1,600 asymptomatic patients who took part in a screening study to detect mammary gland cancer, in an age range of 40 to 65 years, were included. All of them underwent digital mammogram, tomosynthesis, and ultrasound, including in this report only those in whom BIRADS category 3 and 4 nodules detected by ultrasound were confirmed, without representation or not seen in digital mammograms or tomosynthesis. All the studies were evaluated by 5 radiologists with sub-specialization in mammary imaging. RESULTS: of 1,600 patients, BIRADS category 3 and 4 nodules were confirmed in 270, 52 of them detected only by ultrasound and not seen by digital mammogram or tomosynthesis. CONCLUSION: in a dense breast there are greater probabilities of overlooking calcifications, asymmetries, or nodules in digital mammogram or tomosynthesis, which underscores the importance of adding ultrasound to mammogram screening. KEYWORDS: breast cancer; nodules; mammogram; tomosynthesis; mammary ultrasound 1 Médico Radiólogo, Director General. 2 Médico Radiólogo en área de imagen de mama. Centro de Radiodiagnóstico e Imagen S.C. Hidalgo No. 2315 Pte. Colonia Obispado, 64060, Monterrey, N.L. Received: January 22, 2016 Accepted: July 12, 2016 Correspondence Juan Francisco García Quintanilla cderad@prodigy.net.mx This article must be quoted as García-Quintanilla JF, González-Coronado SI, Gascón-Montante A, Hernández-Beltrán L, Barrera- López F, Lavín-Ayala R. Lesiones BIRADS 3 y 4 vistas por ultrasonido y no vistas por mamografía digital y tomosíntesis. Anales de Radiología México 2016;15(3):205-213. www.nietoeditores.com.mx 205

Anales de Radiología México 2016 July;15(3) INTRODUCTION Analogue or digital mammography is considered an effective imaging method for early detection of breast cancer and the only screening method that has proven to reduce breast cancer mortality; 1 however, overlapping breast tissue and high density breasts have made interpretation and detection of lesions difficult. As a recent tool, digital tomosynthesis, as a tomographic modification of digital mammography, adds one more plane to the traditional view, thereby it is referred to as 3D mammography, helping in many cases to reduce or eliminate overlapping in the breast tissue. Images are processed in conventional views, using an algorithm that is similar to the one used in computed tomography. 2 However, even with digital tomosynthesis, the examination of dense breasts to find lesions is still very difficult, especially in case of lesions not surrounded by fat tissue. Breast ultrasound, which was introduced since the seventies in the last century, was initially indicated to differentiate cysts and solid nodules or palpable tumors, and was established as a complementary method after mammography. Since the eighties, it was also considered to be capable of creating a detailed map of breast structure anatomy and to establish the diagnosis of benign or malignant lesions by itself. 3 Currently, the use of breast ultrasound is not limited to the differentiation between solid or cystic lesions, but it also provides additional morphology details to the anatomical structure of the breast as well as to the findings in the study, particularly to each lesion, such as solid nodules; it also has additional tools such as color Doppler, to see the vascularization, as well as elastography, revealing the hardness or stiffness of the lesion to better distinguish between benign and malignant lesions. It is the first method of choice for breast examination in young women having a palpable tumor. 4 Breast ultrasound, combined with clinical examination and mammography, significantly increases sensitivity and specificity of breast exams, especially for dense breasts, that is, breasts with radiopaque stromal and epithelial tissue compared to radiolucent fat elements seen in mammography. 5 Breast ultrasound involves a careful analysis and its effectiveness depends as much on the quality of the equipment as well as the operator, and the ultrasound technician needs to be highly specialized, since the detection of lesions totally depends on his or her perception, resulting in high inter-observer variability. The absence of an image or overall breast tissue pattern makes this method less reproducible. These factors limit the use of ultrasound in some countries, where specialized radiology work is very costly. In malignant palpable tumors, breast ultrasound has 99-100% sensitivity, even with negative mammography. When there is a palpable tumor with negative targeted ultrasound, there is a very low likelihood of finding a cancer. 6 Also, ultrasound is the method of choice to guide percutaneous interventional procedures, such as preoperative marking, fine needle aspiration, core needle biopsy or aspiration biopsy. In select cases ultrasound allows to locate and take a biopsy of microcalcifications clearly identified in mammography. 7 Indications for breast ultrasound 8 Clinical disturbances with or without mammography findings Mammography findings: complement Complementary study of dense breasts Examination of young, pregnant, or breastfeeding patients 206

García-Quintanilla JF et al. BIRADS 3 and 4 lesions viewed by ultrasound Examination of male breasts Nipple secretion study Follow-up of benign lesions Examination of breasts with implants Interventional procedures Second look after MRI Ultrasound in asymptomatic patient screening The recommendation of the American College of Radiology is to classify breasts in 4 categories according to the radiological density of the parenchyma. The BIRADS classification uses the lexicon heterogeneously dense breasts and extremely dense breasts, which could obscure small masses, and decrease sensitivity, and it is well established that sensitivity in mammography decreases as density increases. 5 The relative cancer risk in women with heterogeneously dense breasts, compared to average women is approximately 1:2, and the relative cancer risk in women with extremely dense breasts, compared to average women is 2:1; 9 also, there is an important risk of not finding a small cancer in a dense area in mammography, even with double reading or with digital mammography. On the other hand, there are blind areas in mammography, such as the inframmmary sulcus and the lower inner quadrant, which could be outside the area covered in the examination. False negative results in mammography account for 10 to 30% of studies, mainly because small nodules are not detected. 9 Solid nodules are considered as probably benign, BIRADS 3 in ultrasound when they have no suspicious findings and have 1 to 3 benign criteria, described by Stavros (circumscribed, hyperechoic, ovoid in shape). 10 On mammography, undetermined or suspicious nodules because of their shape and margins (irregular), are considered BIRADS 4, and are best characterized by ultrasound. 11 Several studies agree that 75% of a cancer exclusively detected by ultrasound is under 1 cm. 12 The systematic use of breast ultrasound not only increases cancer detection, but also benign and undetermined lesions. Buchberger, for example, found 365 benign lesions in his series, 60% were solid nodules and 40% complicated cysts. 13 OBJECTIVE Update the evidence on the usefulness of ultrasound in breast cancer detection, at a breast imaging center, focusing on nodules not seen with digital mammography or digital tomosynthesis, mainly in dense breasts, in a prospective study of 1600 patients conducted between February 1 st and May 30, 2015. MATERIAL AND METHODS Prospective study that included 1600 asymptomatic patients that came for breast cancer screening. The age range was 40 to 65 years. Patients had a digital mammography, digital tomosynthesis and ultrasound. This study only includes patients with nodules category BIRADS 3 AND 4, found with ultrasound and not depicted or seen in mammography. Cystic nodules were not included (simple or complicated) or known nodules with benign features and behavior (BI- RADS 2), patients who were followed because of nodules, patients with referred palpable nodules, patients with breast implants, biopsy or previous surgery, and patients who revealed nodules by digital mammography, digital tomosynthesis or ultrasound. All patients were examined using digital mammography, digital tomosynthesis with two 207

Anales de Radiología México 2016 July;15(3) machines Selenia-Dimention (Hologic ), in the usual CC and MLO views, with tomosynthesis in CC view, choosing this view because a greater amount of tissue is covered; 1mm sections were used with variable number of sections in each patient, according to the breast thickness. Ultrasound studies were performed using two Philips IU22 ultrasound machines with 13 and 17 MHz high frequency lineal transducers. All the studies were prospectively evaluated by 5 radiologists who had a breast gland subspecialty, with 5 to 25 years experience in breast examinations. Table 1. Total number of patients (270) BIRADS 3 and 4 Nodules seen on screening mammography Digital mammography, digital tomosynthesis and ultrasound Rate 81 (218) Only with ultrasound 19 (52) Table 2. Nodules seen only with ultrasound (52) BIRADS Rate BIRADS 3 31 (34) BIRADS 4 69 (18) Ethical considerations All studies were performed with informed consent of patients and following ethical medical and institutional codes. RESULTS AND STATISTICAL ANALYSIS Out of 1600 patients included (with digital mammography, digital tomosynthesis and ultrasound) 270 proved to have BIRADS 3 and 4 nodules; of which 52 were seen only by ultrasound (Table 1), category BIRADS 3 (34 cases) and BIRADS 4 (18 cases) (Table 2). As examples we have: BIRADS 3 nodules in patients with pattern b (American College of Radiology) (Figure 1) and nodules with a dense breast pattern (Figure 2), with 1.8 cm diameter (Figure 3), all of which were not found with mammography or tomosynthesis. The size of the observed nodules had a range of 0.4 to 1.8 cm (Table 3). Out of the nodules with BIRADS 4 category (16 cases), 10 had a core needle biopsy, 5 resulted to be carcinomas, the smallest was 0.88 mm and the largest was 1.2 cm. Ductal carcinoma was confirmed in 5, 3 in situ and 2 infiltrating. Examples: BIRADS 4A category nodules (Figure 4) and BIRADS 4b, both resulted in infiltrating ductal cancer (Figure 5). The rest of the suspicious cases are being followed or pending to define treatment. The patients were in a range of 40 to 65 years of age. Due to world incidence and prevalence and the innumerable technological advances, the number of cases with breast cancer diagnosis has constantly increased. The greater the technological advances, the greater the detection of breast cancer, especially in early stages. More women undergo radiological screening studies each day due to greater information and better access. No one can argue that the use of mammography has reduced mortality from this disease when found at early stages. The introduction of different technologies such as ultrasound has allowed to improve diagnosis, especially in patients in whom screening studies (such as digital mammography and digital tomosynthesis) show a dense glandular pattern and also due to the relative cancer risk (1.2) in women with heterogeneously dense breasts and the relative cancer risk (2.1) in women with extremely dense breasts. 9 There is also an important risk of not finding a small cancer in a dense area in mammography, even with double reading or with digital tomosynthesis. Thereby the importance of including ultrasound in breast cancer screening, allowing to show lesions (cysts, solid nodules or 208

García-Quintanilla JF et al. BIRADS 3 and 4 lesions viewed by ultrasound Figure 1. BIRADS 3 nodule (arrow) in patient with pattern b (American College of Radiology). Figure 2. BIRADS 3 nodule (arrow) in 40-year-old patient with dense glandular pattern. 209

Anales de Radiología México 2016 July;15(3) Figure 3. 1.8 cm nodule (arrow), BIRADS 3, not shown on mammography or tomosynthesis, in a dense glandular pattern. Table 3. Size of nodules Size Number of cases 0.1 a 0.5 cm diameter 11 0.6 a 1.0 cm diameter 29 More than 1 cm diameter 12 distorsions) that otherwise would be overlooked, perhaps waiting for the next annual study to be revealed or until they become larger in diameter and palpable in case of neoplasms. This paper focused on the detection of solid, non palpable nodules, not known from previous studies, as well as on their classification according to their ultrasound characteristics; to emphasize the importance of their timely detection in case they are not suspicious (BIRADS 4) or their short term follow-up (BIRADS 3 category) and evaluate their behavior; all this according to the criteria of the American College of Radiology concerning shape, size, outline, content and Doppler vascular pattern or elastography stiffness. 5 A dense breast refers to the relation between the fibroglandular tissue and the fat content, which are criteria that have been well defined by several authors 14 and by the American College of Radiology in four categories that go from less density (A) to more density (D) in mammography. The greater the density of fibroglandular tissue (especially made by the glandular epithelium or acinotubular components, ducts, and intra and interlobular stromal component), the greater the likelihood of overlooking calcifications, asym- 210

García-Quintanilla JF et al. BIRADS 3 and 4 lesions viewed by ultrasound Figure 4. Single nodule (arrow), BIRADS 4A that was reported as infiltrating ductal cancer. Figure 5. BIRADS 4 nodule (arrow) that was reported as infiltrating ductal cancer. 211

Anales de Radiología México 2016 July;15(3) metry or nodules using digital mammography or digital tomosynthesis, and thus the importance of adding ultrasound to screening with mammography, especially in C and D density patterns. 15 CONCLUSION Our study revealed 5 ductal carcinomas by ultrasound, not detected in digital mammography or digital tomosynthesis screening, in patients with dense mammography pattern C and D (American College of Radiology), thereby the importance of including ultrasound in screening these types of mammographic patterns. REFERENCES 1. Skaane P, Bandos AI, Gullien R, et al. Comparison of digital mammography alone and digital mammography plus tomosynthesis in a population-based screening program. Radiology 2013;267(1):47 56. 2. Pragya A. Dang, et al. Addition of tomosynthesis to conventional digital mammography: effect on interpretation, Radiology Volume 270-1- January 2014. 3. Advances in breast ultrasound, Heino Hille, Obstetrics and Gynecology, Hamburg, Germany. www.interchopen.com 4. Barr R et al. Probably benign lesions at screening breast US in a population with elevated risk of breast malignancy, Radiology Volume 269:3-2013. 5. BIRADS, Breast Imaging Report and Data System, ACR 2013. 5- Ed. 6. Berg WA. Supplemental screening sonography in dense breasts. Radiol Clin North Am 2004;42(5):845 851. 7. Ganau S, Ortega R, Master de Senología U de Barcelona 2015. Comunicado. 8. Santamaría G. Master de Senología U de Barcelona 2015. Comunicado. 9. Phoebe E. Feer, Mammographic breast density: Impact on breast cancer and implications for screening, Radiographics 2015; 35;302-315. 10. Stavros T. Breast ultrasound, t book, 2004 edit Lippincot. 11. Sentíes M Master de Senología U de Barcelona 2015. 12. Wenxiang Zhi et al Solid breast lesions: Clinical experience with US. Radiology, 262:2-2012. 13. Buchberger y Renzo Brun del Re, editor en Minimally invasive breast biopsies Springer 2009 14. Winckler et al Breast density and clinical implications. Radiographics 2015,35-2. 15. Min Sun Bae et al. Breast cancer detector with screening US. Reasons for non-detection at mammography. Radiology Volume 270:2-2014. 212